Skip to main content
. 2019 May 2;4(9):e122627. doi: 10.1172/jci.insight.122627

Figure 1. Enrollment of patients in the clinical study.

Figure 1

Status of enrolled patients and schematic of study stages on which patients were treated. 19–28z, 19–28z CAR T cells; Cy, cyclophosphamide; Inv. Choice, investigator’s choice; WM/LPL, Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma